Jul 2026 (Q4 FY26) — Sep 10, 2026
Copart Q4 FY26 — ACV Acquisition and International Growth Drive Strategic Expansion
Read the full callCopart (CPRT) earnings
- Jul 2026
- Jul 2026 (Q4 FY26)
- Jul 2026
Copart earnings: last reported Thu, 10 Sep 2026, for the quarter ended Jul 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,152 | +2.4% YoY | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. |
| Operating margin | 32.0 | −4.7 pts YoY | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. |
| Net profit | 327 | −17.4% YoY | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
2 targets tracked, none judged yet · 2 open · verdicts reflect calls analysed to Apr 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Specialty equipment (Purple Wave) gross transaction value growth | Meaningful growth in specialty equipment GTV over the next 12 to 24 months, as a direct result of the specialty sales team investment | Oct 2024 | GTV has grown over 25% year-over-year. | On Track |
2 of COPART INC's 2 targets are still open. See which are on track and which have gone quiet. The 1 above are the free sample; 1 more target is in the full ledger.
Claimed
- International unit sales were up 10% year-over-year in Q4 FY26.
- International insurance units increased by 11.2% year-over-year in Q4 FY26.
- Global insurance Average Selling Prices (ASPs) were up 3.1% year-over-year in Q4 FY26.
- U.S. non-insurance unit volume returned to modest growth, up 0.2% in Q4 FY26.
- The acquisition of ACV is expected to be accretive to earnings in the first full year (FY28).
Qualified
- Global unit sales were down 2.9% year-over-year in Q4 FY26.
- Domestic unit sales were down 5.7% year-over-year in Q4 FY26.
- Global insurance units decreased by 4.2% year-over-year in Q4 FY26.
- Domestic insurance units were down 7.5% year-over-year in Q4 FY26.
- Operating expense per car was up 12.7% year-over-year in Q4 FY26.
Price
$27.51 −1.29% · −$0.36
Performance −38.0% 1Y
1Y: $44.34 on 17 Oct 2025 → $27.51. High $45.76 (21 Oct 2025), low $26.27 (14 Oct 2026).
- Previous close
- $27.87
- 52-week range
- $26.27 – $45.76
- One year
- −38.54%
Overview
- Symbol
- CPRT
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
2 targets tracked, none judged yet · 2 open · verdicts reflect calls analysed to Apr 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Specialty equipment (Purple Wave) gross transaction value growth | Meaningful growth in specialty equipment GTV over the next 12 to 24 months, as a direct result of the specialty sales team investment | Oct 2024 | GTV has grown over 25% year-over-year. | On Track |
Claimed
- International unit sales were up 10% year-over-year in Q4 FY26.
- International insurance units increased by 11.2% year-over-year in Q4 FY26.
- Global insurance Average Selling Prices (ASPs) were up 3.1% year-over-year in Q4 FY26.
- U.S. non-insurance unit volume returned to modest growth, up 0.2% in Q4 FY26.
- The acquisition of ACV is expected to be accretive to earnings in the first full year (FY28).
Qualified
- Global unit sales were down 2.9% year-over-year in Q4 FY26.
- Domestic unit sales were down 5.7% year-over-year in Q4 FY26.
- Global insurance units decreased by 4.2% year-over-year in Q4 FY26.
- Domestic insurance units were down 7.5% year-over-year in Q4 FY26.
- Operating expense per car was up 12.7% year-over-year in Q4 FY26.
The full ledger
Open COPART INC’s full ledger
A free account opens 5 company ledgers a month. All 2 tracked commitments, with each call’s wording and source.
Call summaries
Apr 2026 (Q3 FY26) — May 21, 2026
Copart Q3 FY26 — Record ASPs and Strong International Growth Offset Volume Headwinds
Read the full callEvery analysed call
Copart earnings calls (CPRT)
Financials
What the filings say
Net profit, year on year: −17% (quarter to jul 2026 against jul 2025).
| Line item | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,147 | 1,163 | 1,212 | 1,125 | 1,155 | 1,122 | 1,237 | 1,152 |
| Expenses | 740 | 737 | 760 | 713 | 724 | 733 | 773 | 784 |
| Operating profit | 406 | 426 | 452 | 413 | 431 | 389 | 464 | 369 |
| Operating margin | 35.4% | 36.6% | 37.3% | 36.7% | 37.3% | 34.6% | 37.5% | 32.0% |
| Other income | 45 | 37 | 51 | 66 | 56 | 52 | 38 | 36 |
| Profit before tax | 451 | 463 | 503 | 478 | 487 | 441 | 502 | 405 |
| Tax rate | 20.0% | 16.5% | 19.4% | 17.4% | 17.4% | 20.6% | 20.1% | 19.2% |
| Net profit | 362 | 387 | 407 | 396 | 404 | 351 | 402 | 327 |
| EPS ($ per share) | 0.38 | 0.40 | 0.42 | — | 0.42 | 0.36 | 0.43 | — |
| Line item | Jul 2019 | Jul 2020 | Jul 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Jul 2025 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 1,338 | 1,938 | 2,868 | 3,956 | 5,189 | 6,546 | 8,093 | 7,981 |
| Total liabilities | 769 | 966 | 1,033 | 683 | 750 | 879 | 883 | 914 |
| Fixed assets | 1,428 | 1,942 | 2,297 | 2,486 | 2,844 | 3,176 | 3,598 | 3,733 |
| Total assets | 2,548 | 3,455 | 4,562 | 5,309 | 6,738 | 8,428 | 10,091 | 10,028 |
| Line item | Jul 2019 | Jul 2020 | Jul 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Jul 2025 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 647 | 918 | 991 | 1,177 | 1,364 | 1,473 | 1,800 | 1,604 |
| Cash from investing | -356 | -601 | -465 | -442 | -1,892 | -940 | -587 | -878 |
| Cash from financing | -370 | -27 | 41 | -383 | 67 | 19 | 52 | -1,607 |
| Net cash flow | -88 | 291 | 571 | 336 | -427 | 557 | 1,266 | -873 |
| Capital expenditure | -374 | -592 | -463 | -337 | -517 | -511 | -569 | -337 |
| Free cash flow | 273 | 326 | 528 | 839 | 848 | 962 | 1,231 | 1,267 |
CPRT revenue by segment
US shrank from 83% to 81% of revenue over the last two years.
| Segment | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| US | 83% | 84% | 83% | 82% | 82% | 82% | 81% | 81% | +0.4% |
| International | — | — | — | — | 18% | 18% | 19% | 19% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q4 FY2026 · share of revenue
- US 81% ↓ 2 pt
As CPRT cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
28 filings between Nov 13, 2025 and Jul 28, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$8.84M
7 sales by 3 insiders
14% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 15
- Option exercise — converted options into shares
Also filed: 5 gifts, 1 other.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| TRYFOROS THOMAS N | — | $3.91M | Nov 25, 2025 |
| Liaw Jeffrey | — | $2.73M | Jul 28, 2026 |
| Englander Daniel J | — | $2.20M | Jul 13, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 3,591 | $24.3K |
| Jul 28, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 43,166 | $375.5K |
| Jul 28, 2026 | Liaw Jeffrey Chief Executive Officer | Sale 10b5-1 plan | 27,745 | $845.9K |
| Jul 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 1,277 | $8.7K |
| Jul 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 812 | $7.1K |
| Jul 13, 2026 | Englander Daniel J Director | Sale | 80,000 | $2.20M |
| Jul 13, 2026 | Englander Daniel J Director | Other | 40,000 | $0 |
| Jul 8, 2026 | Morefield Diane M Director | Option exercise | 50,000 | $988.7K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 4,523 | $30.7K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 43,166 | $375.5K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 809 | $5.5K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 1,277 | $11.1K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Sale | 23,870 | $792.0K |
| Apr 15, 2026 | Liaw Jeffrey Chief Executive Officer | Sale | 2,343 | $77.7K |
| Jan 20, 2026 | ADAIR A JAYSON Executive Chairman | Gift | 7,761 | $0 |
| Jan 20, 2026 | ADAIR A JAYSON Executive Chairman | Gift | 21,200 | $0 |
| Jan 20, 2026 | ADAIR A JAYSON Executive Chairman | Gift | 21,200 | $0 |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 809 | $5.5K |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 1,277 | $11.1K |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 4,523 | $30.7K |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Option exercise | 43,166 | $375.5K |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Sale | 2,444 | $98.2K |
| Jan 15, 2026 | Liaw Jeffrey Chief Executive Officer | Sale | 22,693 | $911.6K |
| Dec 30, 2025 | TRYFOROS THOMAS N Director | Gift | 27,850 | $0 |
| Dec 30, 2025 | TRYFOROS THOMAS N Director | Gift | 27,850 | $0 |
| Nov 25, 2025 | TRYFOROS THOMAS N Director | Option exercise | 100,000 | $1.18M |
| Nov 25, 2025 | TRYFOROS THOMAS N Director | Sale | 100,000 | $3.91M |
| Nov 13, 2025 | Englander Daniel J Director | Option exercise | 100,000 | $1.18M |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise | 809 | $5.5K |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise | 1,277 | $11.1K |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise | 4,523 | $30.7K |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise | 43,166 | $375.5K |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale | 2,197 | $98.4K |
| Oct 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale | 22,086 | $989.2K |
| Sep 15, 2025 | TRYFOROS THOMAS N Director | Sale | 228,840 | $10.88M |
| Sep 15, 2025 | TRYFOROS THOMAS N Director | Option exercise | 228,840 | $1.12M |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 1,277 | $11.1K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale 10b5-1 plan | 3,616 | $169.4K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 4,523 | $30.6K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 43,166 | $375.3K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Option exercise 10b5-1 plan | 809 | $5.5K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale 10b5-1 plan | 1,884 | $87.3K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale 10b5-1 plan | 300 | $14.1K |
| Jul 15, 2025 | Liaw Jeffrey Chief Executive Officer | Sale 10b5-1 plan | 18,288 | $847.7K |
| Apr 14, 2025 | COHAN STEVEN D Director | Sale | 94,997 | $5.70M |
| Apr 14, 2025 | COHAN STEVEN D Director | Option exercise | 94,997 | $1.12M |
| Apr 11, 2025 | COHAN STEVEN D Director | Option exercise | 5,003 | $59.0K |
| Apr 11, 2025 | COHAN STEVEN D Director | Sale | 5,003 | $300.2K |
| Mar 19, 2025 | MEEKS JAMES E Director | Sale | 100,000 | $5.40M |
| Mar 19, 2025 | MEEKS JAMES E Director | Option exercise | 100,000 | $1.18M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for COPART INC
Free account. Everything above stays public.
Write why you follow COPART INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading